Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BTLA Protein, Human, Recombinant (isoform2, His)

(Synonyms: CD272, BTLA1) Copy Product Info

Synonyms: CD272, BTLA1

Catalog No. TMPY-07085 Copy Product Info
BTLA Protein, Human, Recombinant (aa 1-134, His) is expressed in HEK293 Cells. The accession number is Q7Z6A9-2.
BTLA Protein, Human, Recombinant (isoform2, His)
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
5 µg$1557-10 days7-10 days
10 µg$2477-10 days7-10 days
20 µg$3957-10 days7-10 days
50 µg$7107-10 days7-10 days
100 µg$1,1407-10 days7-10 days
200 µg$1,8207-10 days7-10 days
500 µg$3,2707-10 days7-10 days
1 mg$5,2407-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Bioactivity
Immobilized BTLA Protein, Human, Recombinant (aa 1-134, His) (Cat#TMPY-07085) at 2 μg/ml (100 μl/well) can bind Recombinant Mouse HVEM/TNFRSF14 Protein (His & Fc Tag), the EC50 is 11-33 ng/mL.
Description
BTLA Protein, Human, Recombinant (aa 1-134, His) is expressed in HEK293 Cells. The accession number is Q7Z6A9-2.
Species
Human
Expression System
HEK293 Cells
TagC-His
Accession NumberQ7Z6A9-2
ConstructionA DNA sequence encoding the Human BTLA (NP_001078826.1) (Met1-Thr134) was expressed with a polyhistidine tag at the C-terminus.
Protein Purity
≥ 95% as determined by SDS-PAGE. ≥ 95% as determined by SEC-HPLC.
Endotoxin< 1.0 EU/μg of the protein as determined by the LAL method.
FormulationLyophilized from sterile PBS, pH 7.4. Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
ReconstitutionPlease refer to the lot-specific COA.
SynonymsCD272, BTLA1
Research Background
BTLA is a inhibitory molecule which belongs to the Ig superfamily. It down-modulates immune responses. As such, reagents that regulate the binding of BTLA to its ligand or alter BTLA signaling have significant therapeutic promise. BTLA is crucial to understand the mechanism(s) of action of these antibodies before attempting clinical applications. BTLA is not expressed by naive T cells, but it is induced during activation and remains expressed on T helper type 1 (T(H)1) but not T(H)2 cells. BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD-1).Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint TargetsImmunotherapyTargeted Therapy
Chemical Properties
Molecular Weight13.47 kDa (predicted); 30 kDa (reducing contition)
Storage & Solubility Information
ShippingIn general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice.
StorageIt is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.

Calculator

  • Reconstitution Calculator
  • Recombinant Protein Dilution Calculator
  • Specific Activity Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Related Tags: BTLA Protein, Human, Recombinant (isoform2, His) chemical structure | BTLA Protein, Human, Recombinant (isoform2, His) molecular weight